Health News for Seniors: Beer fend off Alzheimer's and Parkinson's diseases ♦ Antibiotics with diuretic can double risk of sudden death ♦ Compound found in grapes may help prevent memory loss

Beer compound could help fend off Alzheimer's and Parkinson's diseases

The health-promoting perks of wine have attracted the spotlight recently, leaving beer in the shadows. But scientists are discovering new ways in which the latter could be a more healthful beverage than once thought. It turns out that a compound from hops could protect brain cells from damage -- and potentially slow the development of disorders such as Alzheimer's and Parkinson's diseases. Continue Reading

Commonly used antibiotics with diuretic can double risk of sudden death in older patients

The combination of the commonly prescribed antibiotic trimethoprim-sulfamethoxazole with the diuretic spironolactone, widely used for heart failure, more than doubles the risk of death for older patients, reports a study Continue Reading

Compound found in grapes, red wine may help prevent memory loss

A compound found in common foods such as red grapes and peanuts may help prevent age-related decline in memory, according to new research. Continue Reading

Dietary Supplement, Hydravax Recalled Hydravax Due to Potential Inclusion of a Diuretic

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.